Robb FujiokaFeb 222 min readScience’s 2023 Breakthrough: GLP-1 Agonists Show Promise Against Obesity-Associated Diseasehttps://youtu.be/QnmMSMF7wO4?si=q_Z91vorvqBT1FSH Originally developed to treat type 2 diabetes nearly 20 years ago, the excitement...